Marshall Wace, LLP Eli Lilly & CO Transaction History

Marshall Wace, LLP

$63.3 Billion
Q1 2024

A detailed history of Marshall Wace, LLP transactions in Eli Lilly & CO stock. As of the latest transaction made, Marshall Wace, LLP holds 423,290 shares of LLY stock, worth $383 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares

423,290

Previous 720,546 41.25%

Holding current value

$383 Million

Previous $420 Million 21.6%

% of portfolio

0.52%

Previous 0.74%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$592.2 - $792.28 $176 Million - $236 Million	-297,256 Reduced 41.25%	423,290 $329 Million
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $66.4 Million - $78.3 Million	126,477 Added 21.29%	720,546 $420 Million
Q3 2023 Nov 14, 2023	BUY	$434.7 - $599.3 $216 Million - $298 Million	497,640 Added 516.07%	594,069 $319 Million
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $208 Million - $278 Million	-592,667 Reduced 86.01%	96,429 $45.2 Million
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $172 Million - $202 Million	553,096 Added 406.69%	689,096 $237 Million

Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $85 Million - $99 Million	-264,245 Reduced 66.02%	136,000 $49.8 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $217 Million - $248 Million	-733,148 Reduced 64.69%	400,245 $129 Million
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $316 Million - $371 Million	1,133,393 New	1,133,393 $367 Million
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $501,532 - $623,277	-2,137 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $34.1 Million - $42.3 Million	-151,748 Reduced 98.61%	2,137 $591,000
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $13.2 Million - $16.2 Million	59,571 Added 63.16%	153,885 $35.6 Million
Q2 2021 Aug 13, 2021	BUY	$180.55 - $233.54 $13.4 Million - $17.3 Million	74,151 Added 367.76%	94,314 $21.6 Million
Q1 2021 May 17, 2021	SELL	$164.32 - $212.72 $31.6 Million - $40.9 Million	-192,051 Reduced 90.5%	20,163 $3.77 Million
Q4 2020 Feb 16, 2021	BUY	$130.46 - $172.63 $3.55 Million - $4.7 Million	27,204 Added 14.7%	212,214 $35.8 Million
Q3 2020 Nov 16, 2020	BUY	$146.22 - $169.13 $3.2 Million - $3.7 Million	21,902 Added 13.43%	185,010 $27.4 Million
Q2 2020 Aug 13, 2020	BUY	$136.42 - $164.18 $22.2 Million - $26.8 Million	163,099 Added 1812211.12%	163,108 $26.8 Million
Q1 2020 May 15, 2020	BUY	$119.05 - $147.35 $476 - $589	4 Added 80.0%	9 $1,000
Q4 2019 Feb 14, 2020	BUY	$106.92 - $132.43 $534 - $662	5 New	5 $1,000
Q3 2018 Nov 14, 2018	SELL	$85.86 - $107.31 $819,533 - $1.02 Million	-9,545 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$75.7 - $86.88 $722,556 - $829,269	9,545 New	9,545 $814,000

Others Institutions Holding LLY

# of Institutions

3,719

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $860B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account

Marshall Wace, LLP Eli Lilly & CO Transaction History